CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Home Formulation development : Ongoing orphan drugs development projects
News
18 Sep 2020

Formulation development : Ongoing orphan drugs development projects

Several ongoing development programs are dedicated to the manufacturing of orphan drugs intended for both US and European patients. Skyepharma team is proud to work on orphan drugs development projects.

Read more
Mentioned Companies
Skyepharma Production S.A.S
View company profile
Related categories
Formulation development Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)